FDA Inspection 1193246 — Michael B. Jacobs, M.D.

Michael B. Jacobs, M.D. — FEI 3024720136

The FDA completed an inspection of Michael B. Jacobs, M.D. on December 20, 2022 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent